In VitroEffect of Lithium Chloride on Interleukin-15 Production by Monocytes from Breast Cancer Patients
Authors:
- A. ArenaAAA. Arena
- S. GangemiSGS. Gangemi
- A. RuelloARA. Ruello
- E. LosiELE. Losi
- A. BeneABA. Bene
- A. ValentiAVA. Valenti
- F. Purello D'AmbrosioFDF. Purello D'Ambrosio
- 1 January 2000
- journal article
- research article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 12 (3) , 252-257
Abstract
Lithium salt compounds are used to limit the degree and duration of neutropenia in patients receiving chemotherapy for cancer. Interleukin-15 (IL-15) is a cytokine which possesses promoting activities on hematopoiesis and is also involved in antitumor response, activating NK, CTL and LAK cells. In this study we analyzed IL-15 production by monocyte cultures treated with lithium chloride (LiCl). Monocytes were obtained from patients affected by non-metastatic and metastatic breast cancer. LiCl treatment induced IL-15 production by monocytes mainly from non-metastatic patients. Combined lipopolysaccharide/LiCl treatment of monocyte cultures up-regulated IL-15 release compared to those treated with LPS alone (p<0.0001). The modulation of LiCl-induced IL-15 could counteract the immunosuppression state of cancer patients, which should be taken into account when developing new immunotherapeutic strategies.Keywords
This publication has 17 references indexed in Scilit:
- Effects of TGF-β on the immune system: implications for cancer immunotherapyLeukemia, 1999
- Interleukin‐15 Induces Antimicrobial Activity after Release byCryptococcus neoformans‐StimulatedMonocytesThe Journal of Infectious Diseases, 1998
- Interleukin-15 and its role in chronic inflammatory diseasesInflammation Research, 1998
- IL-15 Mediates Anti-tumor Effects after Cyclophosphamide Injection of Tumor-Bearing Mice and Enhances Adoptive Immunotherapy: The Potential Role of NK Cell SubpopulationsCellular Immunology, 1997
- Induction by Interleukin‐15 of Human Killer Cell Activity against Lung Cancer Cell Lines and Its Regulatory MechanismsJapanese Journal of Cancer Research, 1996
- Serum levels of interleukin-10 in patients affected by breast cancerImmunology Letters, 1996
- Antitumor activity of three mouse mammary cancer cell lines after interferon-gamma gene transfection*Surgery, 1995
- Serum levels of cytokines in patients with colorectal cancer: Possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasisJournal of Gastroenterology, 1994
- Cloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 ReceptorScience, 1994
- CANCER AND SUBVERSION OF HOST DEFENCESImmunology & Cell Biology, 1981